ALCALAY, MYRIAM
ALCALAY, MYRIAM
Dipartimento di Oncologia ed Emato-Oncologia
Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing
2026 M. Floris, A. Moschella, M. Capasso, M. Alcalay, M.R. Iascone, P. Grammatico, P. Gasparini, M.R. Miozzo, N. Null, C. Mammì, M.L. Idda, L. Fontana, A.P. Capra
Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy
2026 R. Roncato, S. Perfler, M. Gambron, E. Zoroddu, M.R. Miozzo, S. Angelini, M. Gennarelli, G. Stocco, V. Conti, A. Filippelli, P. Borgiani, G. Novelli, A. Squassina, M. Floris, E. Cecchin, N. Null, M. Alcalay, M. Badiali, M. Benati, F.D. Bertola, G. Bianchino, E. Boldrin, E. Bonomi, B. Bortesi, C. Cafiero, D. Calistri, M. Capasso, A.P. Capra, R. Congiu, F. Crosti, M. Curtarello, J. Cusato, G. D'Addario, A. D'Urso, E. De Bellis, D. De Biase, G. De Matteis, M. Dono, M. Fabbri, A. Fabretto, M. Favarato, S. Fogli, A. Franzoni, L. Gallelli, S.R. Giglio, M. Giordano, G. Girotto, P. Grammatico, C. Lapucci, S. Lastraioli, B. Mancini, I. Mancini, S.N. Mellone, P. Menna, R. Minari, R. Mineri, G. Miscio, L. Mosca, A. Moschella, S. Murru, D. Nicoli, S. Orecchia, G. Pessina, C. Rengucci, N. Sacchi, F. Sangiuolo, M. Scatolini, L. Simi, S. Stioui, S. Tabano, L. Toffolatti, S. Tommasi, D. Trerè, A. Ubiali, S. Ulivi, M. Zanussi
Hedgehog and HDAC6 in cancers: dissection of dysregulated biological mechanisms and potential therapeutic treatments
2024 A. Pezzotta, L. Brioschi, S. Carbone, G. Galassi, L. Sicuro, M. Alcalay, G. Carullo, G. Campiani, L. Mollica, A. Marozzi, M. Mione, P. Viani, A. Pistocchi
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
2024 C. Ronchini, C. Caprioli, G. Tunzi, F.F. D'Amico, E. Colombo, M. Giani, G. Foti, D. Conconi, M. Lavitrano, R. Passerini, L. Pase, S. Capizzi, F. Mastrilli, M. Alcalay, R. Orecchia, G. Natoli, P.G. Pelicci
High-Fat Diet Promotes Acute Promyelocytic Leukemia through PPARδ-Enhanced Self-renewal of Preleukemic Progenitors
2024 L. Mazzarella, P. Falvo, M. Adinolfi, G. Tini, E. Gatti, R. Piccioni, E. Bonetti, E. Gavilán, D. Valli, A. Gruszka, M. Bodini, B. Gallo, S. Orecchioni, G. de Michele, E. Migliaccio, B.A. Duso, S. Roerink, M. Stratton, F. Bertolini, M. Alcalay, G.I. Dellino, P.G. Pelicci
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia
2024 C. Ronchini, F. Gigli, M. Fontanini, R. Furgi, V. Amato, F. Giglio, G. Gregato, F. Bertolini, M. Rondoni, F. Lanza, A. Billio, E. Derenzini, C. Tarella, P. Pelicci, Giuseppe, M. Alcalay, E. Todisco
Pharmacogenetics in Italy: current landscape and future prospects
2024 M. Floris, A. Moschella, M. Alcalay, A. Montella, M. Tirelli, L. Fontana, M.L. Idda, P. Guarnieri, M. Capasso, C. Mammì, P. Nicoletti, M. Miozzo
Biomedical omics : first insights of a new MSc degree of the University of Milan
2022 M. Alcalay, B.A. Jereczek-Fossa, M. Pepa, S. Volpe, M. Zaffaroni, F. Fiore, G. Marvaso, G. Pravettoni, G. Curigliano, S. Santaguida, P.G. Pelicci
Targeting Hedgehog and HDAC6 in acute myeloid leukemia in in vitro and zebrafish models
2022 A. Pezzotta, I. Gentile, D. Genovese, M. Totaro, C. Battaglia, A. Leung, M. Fumagalli, M. Parma, M. Alcalay, A. Marozzi, A. Pistocchi
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis
2022 A. Pezzotta, I. Gentile, D. Genovese, M.G. Totaro, C. Battaglia, A.Y. Leung, M. Fumagalli, M. Parma, G. Cazzaniga, G. Fazio, M. Alcalay, A. Marozzi, A. Pistocchi
Hematological disorders after salvage PARPi treatmentfor ovarian cancer: Cytogenetic and molecular defectsand clinical outcomes
2022 E. Todisco, F. Gigli, C. Ronchini, V. Amato, S. Sammassimo, R. Pastano, G. Parma, M. Teresa Lapresa, F. Bertolini, C. Corsini, G. Gregato, C. Poletti, P.G. Pelicci, M. Alcalay, N. Colombo, C. Tarella
Acknowledging and citing core facilities
2022 K. Kivinen, H. Gam Van Luenen, M. Alcalay, C. Bock, J. Dodzian, K. Hoskova, D. Hoyle, O. Hradil, S. Kjellerup Christensen, B. Korn, T. Kosteas, M. Morales, K. Skowronek, V. Theodorou, G. Van Minnebruggen, J. Salamero, L. Premvardhan
HDAC8 promotes hematopoietic stem and progenitor cells proliferation with implications in acute myeloid leukemia
2021 M. Spreafico, A. Gruszka, D. Valli, M. Mazzola, G. Deflorian, A. Quintè, M. Totaro, C. Battaglia, M. Alcalay, A. Marozzi, A. Pistocchi
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
2021 A. Rossi, S. Orecchioni, P. Falvo, V. Tabanelli, E. Baiardi, C. Agostinelli, F. Melle, G. Motta, A. Calleri, S. Fiori, C. Corsini, B. Casadei, S. Mazzara, U. Vitolo, F. Bertolini, P.L. Zinzani, M. Alcalay, P.G. Pelicci, S. Pileri, C. Tarella, E. Derenzini
Cohesin mutations induce chromatin conformation perturbation of the H19/IGF2 imprinted region and gene expression dysregulation in Cornelia de Lange syndrome cell lines
2021 S. Pileggi, M. La Vecchia, E.A. Colombo, L. Fontana, P. Colapietro, D. Rovina, A. Morotti, S.M. Tabano, G. Porta, M. Alcalay, C.C.G. Gervasini, M.R. Miozzo, S.M. Sirchia
HDAC8 : A Promising Therapeutic Target for Acute Myeloid Leukemia
2020 M. Spreafico, A.M. Gruszka, D. Valli, M. Mazzola, G. Deflorian, A. Quinte, M.G. Totaro, C. Battaglia, M. Alcalay, A. Marozzi, A. Pistocchi
Has drug repurposing fulfilled its promise in acute myeloid leukaemia?
2020 D. Valli, A.M. Gruszka, M. Alcalay
Wnt Signalling in Acute Myeloid Leukaemia
2019 A.M. Gruszka, D. Valli, M. Alcalay
Adhesion Deregulation in Acute Myeloid Leukaemia
2019 A.M. Gruszka, D. Valli, C. Restelli, M. Alcalay
Understanding the molecular basis of acute myeloid leukemias : where are we now?
2017 A. M Gruszka, D. Valli, M. Alcalay